Eu­ro­pean Par­lia­ment to dig in­to phar­ma leg­isla­tive re­vi­sion next week

The Eu­ro­pean Par­lia­ment’s pub­lic health com­mit­tee will meet next Tues­day to dis­cuss and vote on long-await­ed leg­isla­tive fix­es meant to en­cour­age more bio­phar­ma in­vest­ment across the EU.

The re­forms were first un­veiled last April, and com­pa­nies that pro­vide ac­cess to their med­i­cines in all Eu­ro­pean mem­ber states would be re­ward­ed with two ex­tra years of da­ta pro­tec­tion. But in­dus­try groups like EF­PIA have tak­en is­sue with the re­vi­sion, ar­gu­ing it would ef­fec­tive­ly pe­nal­ize com­pa­nies that can­not make a med­i­cine avail­able across the con­ti­nent with­in two years of launch.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER